Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
3.600
-0.130 (-3.49%)
At close: Jul 11, 2025, 4:00 PM
3.580
-0.020 (-0.56%)
After-hours: Jul 11, 2025, 7:59 PM EDT
Relay Therapeutics Market Cap
Relay Therapeutics has a market cap or net worth of $617.20 million as of July 11, 2025. Its market cap has decreased by -31.01% in one year.
Market Cap
617.20M
Enterprise Value
-45.99M
1-Year Change
-31.01%
Ranking
Category
Stock Price
$3.60
Market Cap Chart
Since July 16, 2020, Relay Therapeutics's market cap has decreased from $3.03B to $617.20M, a decrease of -79.66%. That is a compound annual growth rate of -27.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 617.20M | -10.50% |
| Dec 31, 2024 | 689.62M | -49.19% |
| Dec 29, 2023 | 1.36B | -24.86% |
| Dec 30, 2022 | 1.81B | -45.57% |
| Dec 31, 2021 | 3.32B | -11.11% |
| Dec 31, 2020 | 3.73B | 22.99% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 703.38B |
| Johnson & Johnson | 375.78B |
| AbbVie | 339.70B |
| Novo Nordisk | 316.64B |
| UnitedHealth Group | 272.52B |
| Novartis AG | 243.81B |
| Abbott Laboratories | 228.95B |
| AstraZeneca | 223.49B |